doi:10.3969/j.issn.1004-583X.2022.01.013

Abstract

CLC Number:

R589

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.01.013

https://huicui.hebmu.edu.cn/EN/Y2022/V37/I1/66

References 46

[1]	Pérez A, Ramos A, Carreras G. Insulin therapy in hospitalized patients[J]. Am J Ther, 2020, 27(1):e71-e78. doi: 10.1097/MJT.0000000000001078 URL
[2]	Salinas PD, Mendez CE. Glucose management technologies for the critically ill[J]. J Diabetes Sci Technol, 2019, 13(4):682-690. doi: 10.1177/1932296818822838 pmid: 30638048
[3]	Carpenter DL, Gregg SR, Xu K, et al. Prevalence and impact of unknown diabetes in the ICU[J]. Crit Care Med, 2015, 43(12):e541-e550. doi: 10.1097/CCM.0000000000001353 URL
[4]	Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients[J]. N Engl J Med, 2001, 345(19):1359-1367. doi: 10.1056/NEJMoa011300 URL
[5]	Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis[J]. N Engl J Med, 2008, 358(2):125-139. doi: 10.1056/NEJMoa070716 URL
[6]	Agus MS, Wypij D, Hirshberg EL, et al. Tight glycemic control in critically ill children[J]. N Engl J Med, 2017, 376(8):729-741. doi: 10.1056/NEJMoa1612348 URL
[7]	NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients[J]. N Engl J Med, 2009, 360(13):1283-1297. doi: 10.1056/NEJMoa0810625 URL
[8]	Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit[J]. Clin Nutr, 2019, 38(1):48-79. doi: 10.1016/j.clnu.2018.08.037 URL
[9]	Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016[J]. Intensive Care Med, 2017, 43(3):304-377. doi: 10.1007/s00134-017-4683-6 URL
[10]	Chase JG, Desaive T, Bohe J, et al. Improving glycemic control in critically ill patients: Personalized care to mimic the endocrine pancreas[J]. Crit Care, 2018, 22(1):182. doi: 10.1186/s13054-018-2110-1 URL
[11]	Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: An international multicenter cohort study[J]. Crit Care, 2013, 17(2):R37. doi: 10.1186/cc12547 URL
[12]	Egi M, Bellomo R, Stachowski E, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes[J]. Crit Care Med, 2008, 36(8):2249-2255. doi: 10.1097/CCM.0b013e318181039a URL
[13]	Di Muzio F, Presello B, Glassford NJ, et al. Liberal versus conventional glucose targets in critically ill diabetic patients: An exploratory safety cohort assessment[J]. Crit Care Med, 2016, 44(9):1683-1691. doi: 10.1097/CCM.0000000000001742 URL
[14]	Kar P, Plummer MP, Bellomo R, et al. Liberal glycemic control in critically ill patients with type 2 diabetes: An exploratory study[J]. Crit Care Med, 2016, 44(9):1695-1703. doi: 10.1097/CCM.0000000000001815 URL
[15]	Luethi N, Cioccari L, Biesenbach P, et al. Liberal glucose control in ICU patients with diabetes: A before-and-after study[J]. Crit Care Med, 2018, 46(6):935-942. doi: 10.1097/CCM.0000000000003087 pmid: 29509570
[16]	Poole AP, Finnis ME, Anstey J, et al. Study protocol and statistical analysis plan for the liberal glucose control in critically ill patients with pre-existing type 2 diabetes (LUCID) trial[J]. Crit Care Resusc, 2020, 22(2):133-141.
[17]	Egi M, Krinsley JS, Maurer P, et al. Pre-morbid glycemic control modifies the interaction between acute hypoglycemia and mortality[J]. Int Care Med, 2016, 42(4):562-571. doi: 10.1007/s00134-016-4216-8 URL
[18]	van Keulen K, Knol W, Belitser SV, et al. Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study[J]. PLoS One, 2018, 13(11):e0205637.
[19]	Mifsud S, Schembri EL, Gruppetta M. Stress-induced hyperglycaemia[J]. Br J Hosp Med (Lond), 2018, 79(11):634-639. doi: 10.12968/hmed.2018.79.11.634 URL
[20]	Krinsley JS, Maurer P, Holewinski S, et al. Glucose control, diabetes status, and mortality in critically ill patients: the continuum from intensive care unit admission to hospital discharge[J]. Mayo Clin Proc, 2017, 92(7):1019-1029. doi: S0025-6196(17)30320-8 pmid: 28645517
[21]	Lanspa MJ, Krinsley JS, Hersh AM, et al. Percentage of time in range 70 to 139 mg/dL is associated with reduced mortality among critically ill patients receiving IV insulin infusion[J]. Chest, 2019, 156(5):878-886. doi: 10.1016/j.chest.2019.05.016 URL
[22]	Papachristoforou E, Lambadiari V, Maratou E, et al. Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications[J]. J Diabetes Res, 2020, 2020:7489795.
[23]	Hsu CW, Sun SF, Lin HS. Glycemic variability in critically ill patients: Risk factors and association with mortality[J]. Chin Med J (Engl), 2020, 133(10):1255-1256.
[24]	Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: An international multicenter cohort study[J]. Crit Care, 2013, 17(2):R37. doi: 10.1186/cc12547 URL
[25]	Fabbri A, Marchesini G, Benazzi B, et al. Stress hyperglycemia and mortality in subjects with diabetes and sepsis[J]. Crit Care Explor, 2020, 2(7):e0152. doi: 10.1097/CCE.0000000000000152 URL
[26]	Rau CS, Wu SC, Chen YC, et al. Stress-induced hyperglycemia in diabetes: A cross-sectional analysis to explore the definition based on the trauma registry data[J]. Int J Environ Res Public Health, 2017, 14(12):1527. doi: 10.3390/ijerph14121527 URL
[27]	Chu J, Tang J, Lai Y, et al. Association of stress hyperglycemia ratio with intracoronary thrombus burden in diabetic patients with ST-segment elevation myocardial infarction[J]. J Thorac Dis, 2020, 12(11):6598-6608. doi: 10.21037/jtd URL
[28]	Nathan DM, Kuenen J, Borg R, et al. Translating the A₁C assay into estimated average glucose values[J]. Diabetes Care, 2008, 31(8):1473-1478. doi: 10.2337/dc08-0545 pmid: 18540046
[29]	Liang Y, Wanderer J, Nichols JH, et al. Blood gas analyzer accuracy of glucose measurements[J]. Mayo Clin Proc, 2017, 92(7):1030-1041. doi: 10.1016/j.mayocp.2017.03.009 URL
[30]	Stadlbauer V, Wallner S, Stojakovic T, et al. Comparison of 3 different multianalyte point-of-care devices during clinical routine on a medical intensive care unit[J]. J Crit Care, 2011, 26(4):433.e1-e11. doi: 10.1016/j.jcrc.2010.09.003 URL
[31]	Cembrowski G, Jung J, Mei J, et al. Five-year two-center retrospective comparison of central laboratory glucose to GEM 4000 and ABL 800 blood glucose: Demonstrating the (In)adequacy of blood gas glucose[J]. J Diabetes Sci Technol, 2020, 14(3):535-545. doi: 10.1177/1932296819883260 pmid: 31686527
[32]	胥小芳, 孙红, 李春燕, 等. 《动脉血气分析临床操作实践标准》要点解读[J]. 中国护理管理, 2017, 17(9):1158-1161.
[33]	Le HT, Harris NS, Estilong AJ, et al. Blood glucose measurement in the intensive care unit: What is the best method?[J]. J Diabetes Sci Technol, 2013, 7(2):489-499. doi: 10.1177/193229681300700226 URL
[34]	Montero AR, Dubin JS, Sack P, et al. Future technology-enabled care for diabetes and hyperglycemia in the hospital setting[J]. World J Diabetes, 2019, 10(9):473-480. doi: 10.4239/wjd.v10.i9.473 pmid: 31558981
[35]	Bruen D, Delaney C, Florea L, et al. Glucose sensing for diabetes monitoring: Recent developments[J]. Sensors (Basel), 2017, 17(8):1866. doi: 10.3390/s17081866 URL
[36]	中华医学会糖尿病学分会. 中国持续葡萄糖监测临床应用指南(2017年版)[J]. 中华糖尿病杂志, 2017, 9(11):667-675.
[37]	Schierenbeck F, Franco-Cereceda A, Liska J. Accuracy of 2 different continuous glucose monitoring systems in patients undergoing cardiac surgery[J]. J Diabetes Sci Technol, 2017, 11:108-116. doi: 10.1177/1932296816651632 pmid: 27257168
[38]	余洁, 丁亚萍, 许勤, 等. 一种连续动脉血糖监测设备的创新思路及设计方案[J]. 中华危重病急救医学, 2019, 31(7):906-909.
[39]	Wallia A, Umpierrez GE, Rushakoff RJ, et al. Consensus statement on inpatient use of continuous glucose monitoring[J]. J Diabetes Sci Technol, 2017, 11(5):1036-1044. doi: 10.1177/1932296817706151 URL
[40]	Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project[J]. Endocr Pract, 2004, 10(Suppl 2):21-33.
[41]	Avanzini F, Marelli G, Saltafossi D, et al. Effectiveness, safety and feasibility of an evidence-based insulin infusion protocol targeting moderate glycaemic control in intensive cardiac care units[J]. Eur Heart J Acute Cardiovasc Care, 2016, 5(2):117-124. doi: 10.1177/2048872615574110 pmid: 25735300
[42]	Clergeau A, Parienti JJ, Reznik Y, et al. Impact of a paper-based dynamic insulin infusion protocol on glycemic variability, time in target, and hypoglycemic risk: a stepped wedge trial in medical intensive care unit patients[J]. Diabetes Technol Ther, 2017, 19(2):115-123. doi: 10.1089/dia.2016.0314 URL
[43]	郁慧杰, 张玲芳, 许嵩翱, 等. 血糖控制胰岛素用量调节卡尺对急危重患者的血糖控制[J]. 中华危重病急救医学, 2018, 30(8):771-776.
[44]	Alamri N, Seley JJ. Evaluation of several electronic glycemic management systems[J]. J Diabetes Sci Technol, 2018, 12(1):60-62. doi: 10.1177/1932296817751748 URL
[45]	Fogel SL, Baker CC. Effects of computerized decision support systems on blood glucose regulation in critically ill surgical patients[J]. J Am Coll Surg, 2013, 216(4):828-835. doi: 10.1016/j.jamcollsurg.2012.12.015 URL
[46]	Tanenberg RJ, Hardee S, Rothermel C, et al. Use of a computer-guided glucose management system to improve glycemic control and address national quality measures: a 7-year, retrospective observational study at a tertiary care teaching hospital[J]. Endocr Pract, 2017, 23(3):331-341. doi: 10.4158/EP161402.OR pmid: 27967226

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 46

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liu Jing, Luo Na, Feng Shangyong, Wang Yan, Zhang Zhenwen, She Dunmin. Prevalence and risk factors of hyperuricemia in health examination population in Yangzhou, 2020 [J]. Clinical Focus, 2023, 38(5): 428-432.
[2]	Han Tuo, Wang Lixia, Wang Yiwen, Li Ying, Gong Hong, Zhang Chunyan, Zhang Yan, Li Yongqin, Wang Congxia. Correlation analysis between dietary nutrient intake with blood glucose and insulin resistance in healthy population [J]. Clinical Focus, 2023, 38(2): 126-131.
[3]	Chai Chunyan, Wang ting. Clinical analysis of three elderly patients with hypercalcemia and literature review [J]. Clinical Focus, 2023, 38(2): 166-169.
[4]	. [J]. Clinical Focus, 2022, 37(11): 1044-1047.
[5]	Zhang Shu, Bao Yun, Chen Fang, Shan Qing. Predictive value of body composition and anthropometry for dyslipidemia in postmenopausal women [J]. Clinical Focus, 2022, 37(8): 708-712.
[6]	. [J]. Clinical Focus, 2022, 37(7): 658-662.
[7]	. [J]. Clinical Focus, 2022, 37(5): 477-480.
[8]	Cui Qingyang, Liu Juan, Cao Yinli, Zhang Chunyan, Wang Xicheng. Ornithine carbamoyltransferase deficiency caused by one female newborn: A case report and literature review [J]. Clinical Focus, 2021, 36(12): 1128-1131.
[9]	Zhao Wei, Luo Lan, Li Shen, Dong Yingying, Li Xinyu, Gao Zhengnan. TG/HDL-C, TyG and non-HDL-C in predition of metabolic syndrome incidence in middle-aged and elderly women [J]. Clinical Focus, 2021, 36(9): 790-794.
[10]	Li Yaru, Zhao Haiying, Ji Xiaoyi, Wang Menglin, Wang Hao, Li Ling, Jiang Ling, Wang Xinyu. Correlation between serum uric acid and catecholamines in college students [J]. Clinical Focus, 2021, 36(4): 357-360.
[11]	Lyu Yixuan, Lu Zhanfei, Sun Nianzhe, Li Fuhan, Liu Rong. Systematic review on the efficacy of dual-energy CT and ultrasound in the diagnosis of gout [J]. Clinical Focus, 2021, 36(1): 5-7.
[12]	Hu Yatinga, Liang Zhipingb, Zhang Junchen, Xu Wuhuaa. One case report and literature review of SSCNS [J]. Clinical Focus, 2020, 35(12): 1116-1119.
[13]	Wang Xuepeng, Zhou Ye, Xu Bin, Jin Yong, Zhou Renke, Li Li. Effect of Ningbo Branch Center of the National Metabolic Management Center on blood glucose management in patients with type 2 diabetes mellitus [J]. Clinical Focus, 2020, 35(11): 992-996.
[14]	Yang Peilong;Wang Lixin;Yuan Fang;Gao Jinchai. Rosuvastatin on inflammatory cytokines and ankle-brachial index in mild-moderate hypertensive patients with hyperlipemia [J]. Clinical Focus, 2015, 30(12): 1363-1366.
[15]	Gao Suying;Yu Kai;Wang Yongjun;Yan Yinglin;Zhao Yongna;Zhang Huiling;Kong Yana. Comparison of four diagnostic criteria of metabolic syndrome in elderly residents in Hebei Renqiu [J]. Clinical Focus, 2015, 30(9): 992-996.